CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
February 2019—CellMax Life announced the kickoff of its Zenith study, a U.S. clinical study for the company’s circulating tumor cell blood test.
Read More »February 2019—CellMax Life announced the kickoff of its Zenith study, a U.S. clinical study for the company’s circulating tumor cell blood test.
Read More »